D-dimer at hospital admission for COVID-19 are associated with in-hospital mortality, independent of venous thromboembolism: Insights from a French multicenter cohort study

[1]  E. Messas,et al.  Predictive Factor for COVID-19 Worsening: Insights for High-Sensitivity Troponin and D-Dimer and Correlation With Right Ventricular Afterload , 2020, Frontiers in Medicine.

[2]  T. Soumagne,et al.  Elevated D-dimers and lack of anticoagulation predict PE in severe COVID-19 patients , 2020, European Respiratory Journal.

[3]  R. Favory,et al.  Pulmonary Embolism in Patients With COVID-19 , 2020, Circulation.

[4]  A. Cohen,et al.  Pulmonary embolism in COVID-19 patients: a French multicentre cohort study , 2020, European heart journal.

[5]  D. Lebeaux,et al.  Curative anticoagulation prevents endothelial lesion in COVID‐19 patients , 2020, Journal of Thrombosis and Haemostasis.

[6]  N. Tang,et al.  Coagulation dysfunction: A hallmark in COVID-19. , 2020, Archives of pathology & laboratory medicine.

[7]  K. Ferdinand,et al.  Association of cardiac biomarkers and comorbidities with increased mortality, severity, and cardiac injury in COVID‐19 patients: A meta‐regression and decision tree analysis , 2020, Journal of medical virology.

[8]  E. Messas,et al.  Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients , 2020, Angiogenesis.

[9]  F. Jalali,et al.  Routine Venous Thromboembolism Prophylaxis May Be Inadequate in the Hypercoagulable State of Severe Coronavirus Disease 2019 , 2020, Critical care medicine.

[10]  J. Douketis,et al.  Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID‐19 , 2020, Journal of Thrombosis and Haemostasis.

[11]  Axel Haverich,et al.  Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. , 2020, The New England journal of medicine.

[12]  H. Merdji,et al.  Prothrombotic phenotype in COVID-19 severe patients , 2020, Intensive Care Medicine.

[13]  D. Smadja,et al.  Is COVID-19 a New Hematologic Disease? , 2020, Stem Cell Reviews and Reports.

[14]  J. Connors,et al.  COVID-19 and its implications for thrombosis and anticoagulation , 2020, Blood.

[15]  A. Curnis,et al.  Acute pulmonary embolism in COVID-19 disease: Preliminary report on seven patients , 2020, International Journal of Cardiology.

[16]  Holger Moch,et al.  Endothelial cell infection and endotheliitis in COVID-19 , 2020, The Lancet.

[17]  Fergus Gleeson,et al.  COVID-19 patients and the radiology department – advice from the European Society of Radiology (ESR) and the European Society of Thoracic Imaging (ESTI) , 2020, European Radiology.

[18]  L. Beenen,et al.  Incidence of venous thromboembolism in hospitalized patients with COVID‐19 , 2020, Journal of Thrombosis and Haemostasis.

[19]  Q. Fan,et al.  D‐dimer levels on admission to predict in‐hospital mortality in patients with Covid‐19 , 2020, Journal of Thrombosis and Haemostasis.

[20]  David Berlin,et al.  Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases , 2020, Translational Research.

[21]  A. Falanga,et al.  ISTH interim guidance on recognition and management of coagulopathy in COVID‐19 , 2020, Journal of Thrombosis and Haemostasis.

[22]  Xiang Xie,et al.  COVID-19 and the cardiovascular system , 2020, Nature Reviews Cardiology.

[23]  J. Xiang,et al.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.

[24]  K. Yuen,et al.  Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.

[25]  Dengju Li,et al.  Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia , 2020, Journal of Thrombosis and Haemostasis.

[26]  Y. Hu,et al.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.

[27]  P. Sedgwick.  Bias in observational study designs: cross sectional studies , 2015, BMJ : British Medical Journal.

[28]  P. Austin.  An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies , 2011, Multivariate behavioral research.

[29]  D. Diz,et al.  Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2 , 2005, Circulation.

[30]  Viv Bewick,et al.  Statistics review 10: Further nonparametric methods , 2004, Critical care.

[31]  G. Lippi,et al.  Harmonisation of D-dimer - A call for action. , 2016, Thrombosis research.

[32]  M. Reichenheim,et al.  Measures and models for causal inference in cross-sectional studies: arguments for the appropriateness of the prevalence odds ratio and related logistic regression , 2010, BMC medical research methodology.